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The rice fermented by Monascus, called red mold rice (RMR), and has a long tradition in East Asia as a dietary staple. Monascus-
fermented dioscorea called red mold dioscorea (RMD) contains various metabolites to perform the ability of reducing oxidative
stress and anti-inﬂammatoryresponse. We used Wistar rats and induced diabetes by injecting streptozotocin (STZ,65mg/kgi.p.).
RMD was administered daily starting six weeks after disease onset. Throughout the experimental period, signiﬁcantly (P<. 05)
lowered plasma glucose, triglyceride, cholesterol, free fatty acid and low density lipoprotein levels were observed in the RMD-
treated groups. The RMD-treated diabetic rats showed higher activities of glutathione disulﬁde reductase, glutathione reductase,
catalaseandsuperoxide dismutase(P<. 05)in thepancreas compared with the diabetic control rats.RMD alsoinhibited diabetes-
inducedelevationinthelevelsofinterleukin (IL)-1β,IL-6,interferon-γ andtumornecrosisfactor-α.P anc r e at icβ-cells damagedby
STZintheRMDsupplementedgroupswere ameliorated.The resultsofthisstudy clearlydemonstratedthatRMDpossessesseveral
treatment-oriented properties, including the control of hyperglycemia, antioxidant eﬀects, pancreatic β-cell protection and anti-
inﬂammatory eﬀects. Considering these observations, it appears that RMD may be a useful supplement to delay the development
of diabetes and its complications.
1.Introduction
Diabetes mellitus is a metabolic disease resulting from in-
sulin deﬁciency, leading to high blood glucose levels and hy-
perglycemia [1]. Hyperglycemia resulting from defection in
insulin action or insulin production leads to a number of
complications[2].Thebiochemicalparameters changes such
as formation of advanced glycation end products (AGEs)
have increased the expression of proinﬂammatory cytokine
genes[3].Diabeticcomplicationshavedemonstratedthatthe
production of excess reactive oxygen species (ROS) leads to
tissue injury or apoptosis [4]. The reduction of antioxidant
enzyme activities and tissue glutathione (GSH) levels have
been reported in diabetes mellitus [3]. Both oxidative stress
and inﬂammation play a major role in the development of
tissue insulin resistance [5].
Streptozotocin (STZ) is the most commonly used chem-
ical to induce experimental diabetes in animals. Glucose
overload may damage the cells through oxidative stress and
inﬂammation, and oxidative stress has been suggested to be
a contributory factor in the pathogenesis of diabetes [6, 7].
Hyperglycemia increases the inﬂammatory markers’ tumor
necrosis factor (TNF)-α, interleukin (IL)-1, and IL-6 [8, 9].
Overproduced proinﬂammatory cytokines enhances inﬂam-
matory stress in diabetes and diabetic complications. A great
deal of evidence indicates close ties between inﬂammatory
and metabolic pathways [10–12].
The solid state fermentation of rice by Monascus, called
red mold rice (RMR), has a long tradition in East Asia as a
dietary staple and food additive, which improves the diges-
tion and revitalizes the blood [13, 14]. Monacolin K (lovas-
tatin), an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme2 Experimental Diabetes Research
A (HMG-CoA) reductase, is a worthy secondary metabolite
found in RMR to inhibit the biosynthesis of cholesterol
for treating hyperlipidemia [15]. RMR has been proven to
improve the memory and learning ability in Aβ-infused
rats, reduces the tumor progression of Lewis lung carcinoma
cells and prevents the development of obesity [16–19]. RMR
contains various metabolites, including dimerumic acid,
tannin, phenol, and azaphilones [20], to perform the ability
of antioxidative stress and anti-inﬂammatory response [20,
21].
Yam tubers of Dioscorea genus have been used as tra-
ditional medical herb substances [22], health food supple-
ments and functional foods, for the treatment of diabetes
in China [23]. Yam tubers have a multiple biological eﬀect,
including reducing blood glucose [24], lowering blood lipids
[25], promoting an antitumor eﬀect [26], and possessing
antioxidantproperties[27].Thepresenceofvariousphenolic
compounds has been reported in yam tuber tissue, such as
(+)-catechin [28] and cinnamic compounds [29].
According to the authors’ knowledge, there has been no
detailed study carried out to investigate the eﬃcacy of red
mold dioscorea (RMD) in the antioxidative and anti-inﬂa-
mmatory activity associated with diabetes in experiments on
animals. This study determined thecontentofphenolicacids
from RMD and examined antidiabetic, antioxidative, and
anti-inﬂammatory eﬀects in STZ-induced diabetic rats. The
aim of the present study was to evaluate the chemopreven-
tion of RMD in a diabetic animal model. The cytokine and
antioxidation enzyme proﬁle of STZ responses in the tissue
were further analyzed.
2.Materialsand Methods
2.1. Sample Preparation. Monascus purpureus NTU 568 was
maintained on potato dextrose agar (PDA) slant at 4◦Ca n d
transferred monthly. The preparation of red mold dioscorea
(RMD) was carried out using the substrates of dioscorea
(Dioscorea batatas Dence) root. Solid-state culture method
was used to prepare the fermented contents [16]. At the end
of cultivation, the crushed and dried products with the mold
were used for the experiments.
2.2. Analysis of Phenolic Compounds. Total polyphenolic
compounds were extracted from 0.5g of red mold dioscorea
with 5mL of methanol/1.5N HCl (85/15, v/v) for 1hr at
ambient temperature (27–30◦C). The suspension was cen-
trifuged at 7,000×g for 5min. The supernatant was ﬁltered
through 0.45μm pore size ﬁlter, and 100μLw a si n j e c t e d
onto the high performance liquid chromatography (HPLC)
system [30]. HPLC analyses were operated by an HPLC
system (Agilent 1100 series, Santa Clara, CA, USA) and
carried out ona Mightysil RP-18 GP column(250 × 4.6mm,
Kanto Chemical, Tokyo, Japan). The assay method and
solvent system were derived from that of Akissoe et al.
[30]. Commercial phenolic standards were characterized by
their retention times and coinjected with red mold dioscorea
extracts to identify the peaks.
2.3. Animals and Experimental Design. Male Wistar rats,
weighting 140–160g, aged 5-6 weeks, were used for this ex-
periment. The experiments were carried out in a qualiﬁed
animal breeding room in the Animal Center at our institute
(protocol complied with guidelines described in the “Animal
Protection Law”, amended on Jan. 17, 2001 Hua-Zong-
(1)-Yi-Tzi-9000007530, Council of Agriculture, Executive
Yuan, Taiwan, ROC). Diabetes were induced by injecting
intraperitoneally with 65mg/kg streptozotocin (STZ, Sigma,
St Louis, MO, USA) in 0.1M acetate buﬀer and 230mg/kg
nicotinamide after fasting for 12 to 24hrs. Rats with plasma
glucose concentration of 200mg/dL or greater were consid-
ered as diabetic animals and used in this study. The animals
were randomly divided into six groups and each group
contained six animals. Age-matched normal rats served as
normal control (NC). Diabetic rats were divided into ﬁve
groups: group 1: diabetic control (DC); group 2 received
dioscorea 200mg/kg (DM (diabetes mellitus) + 1X D);
group 3 received red mold dioscorea 100mg/kg (DM + 0.5X
RMD); group 4 received RMD 200mg/kg (DM + 1X RMD);
group 5 received RMD 1,000 mg/kg (DM + 5X RMD). Rats
were anaesthetized and sacriﬁced at the end of the 6-week
treatment; the pancreas, spleen, and kidney were excised and
washed thoroughly to clear oﬀ blood.
2.4. Biochemical Analysis. Blood glucose, triglyceride (TG),
total cholesterol (TC), high density lipoprotein cholesterol
(HDL-C), low density lipoprotein cholesterol (LDL-C),
serum insulin, serum-free fatty acid (FFA), and total protein
were measured at 6 weeks of red mold dioscorea treatment.
Blood glucose was immediately determined by the glucose
oxidase method, using an analyzer [31]. Serum insulin was
measured using an enzyme-linked immunosorbent assay
(ELISA)insulin kit(MercodiaAB,Uppsala,Sweden).Plasma
TG, TC, HDL-C, LDL-C, FFA, and total protein levels
were measured in triplicate using an automatic biochemical
analyzer (Beckman-700, Fullerton, CA, USA).
2.5. Antioxidant Enzymes Activities. Following the termina-
tion of the animals, pancreas was immediately removed and
homogenized with ice-cold 0.1 N Tris-HCl buﬀer (pH 7.4)
(1:10, w/v). After centrifugation at 2,500×gf o r3 0m i na t
4◦C, the supernatant was collected for the measurement of
antioxidant enzymes activities. The analysis of level of reac-
tive oxygen species (ROS), activity of glutathione peroxidase
(GPx), activity of glutathione reductase (GR), and activity
of catalase (CAT) was carried out according to the methods
previously reported [32–35]. The activity of superoxide
dismutase (SOD) was determined by commercially available
k i t( C a y m a n ,A n nA r b o r ,M I ,U S A ) .
2.6. Cytokine Analyses. Tissues were immediately removed
and homogenized with ice-cold 10mM Tris-HCl buﬀer (pH
7.4) [36]. After centrifugation at 9,000×gf o r3 0 m i na t
4◦C, the supernatant was collected for the measurement
of cytokines. The levels of IL-1β,T N F - α,I L - 2 ,I L - 6 ,a n d
interferon(IFN)-γ weremeasuredbyELISAusingcytoscreen
immunoassay kits (Peprotech, Rocky Hill, NJ, USA).Experimental Diabetes Research 3
2.7. Assay of Splenocytes Proliferation. Splenocytes (1 ×
107) from splenic tissue were suspended in RPMI-1640
medium with 10% fetal bovine serum, 2mM glutamine,
and 100 units of penicillin-streptomycin. Subsequently,
the splenocytes were activated with phytohemagglutinin
(PHA, Sigma) (20μg/mL) and lipopolysaccharide (LPS,
Sigma) (20μg/mL). The cells were incubated at 37◦C
for 72hrs. 3-(4,5)-Dimethylthiahiazol-2-yl-2,5-di-phenytet-
razoliumromide (MTT, Sigma) were pulsed into each well
during the ﬁnal 6hrs of incubation. The media was removed
with a needle and syringe and dimethyl sulfoxide (DMSO,
Kanto Chemical) was added to each well. Absorbance at
600nm was measured.
2.8. Histological and Immunohistochemistry Assay. Pancreas
tissues taken from experimental animals were ﬁxed in 10%
neutral formalin, alcohol-dehydrated, paraﬃn-embedded
and the section were cut at 4μm thickness. Sections were
stained with hematoxylin and eosin (H & E). Adjacent
secretions were also stained for insulin. Rabbitantirat insulin
antibody (Cell Signaling, Danvers, MA, USA) was detected
with an antirabbit avidin-biotinylated horseradish perox-
idase complex (ABC) kit according to the manufacturer
instructions (Vector, Burlingame, CA, USA). The degree
of insulin expression in diﬀerent groups was evaluated by
software Image J (NIH, Maryland, MD, USA).
2.9. Statistical Analysis. Data are expressed as the mean ±
SD. The statistical signiﬁcance was carried out using one-
way analysis of variance test followed by Duncan’s Multiple
Range Test (SPSS statistical software package, version 12.0,
SPSS,Chicago,IL,USA).ApossibilityofPvaluelessthan .05
was considered as signiﬁcantly diﬀerent between means.
3.Results
3.1. Phenolic Compounds of Red Mold Dioscorea. Phenolic
acids are aromatic secondary metabolites from plant and
fungi [37] which have been associated with the color
and nutritional and antioxidant properties of food [38].
Figure 1(a) shows chromatograms recorded at 280nm for
phenolic acid standards. The phenolic acid composition of
red molddioscorea (RMD)isgiveninFigure 1(b).TheRMD
sample contained 2.01mg gallic acid/100g FW, 22.58mg
vanillic acid/100g FW, 2.67mg caﬀeic acid/100g FW,
10.87mg epicatechin/100g FW, and 3.54mg coumaric/100g
FW. The contents of phenolic compounds in dioscorea were
lower than Monascus-fermented dioscorea (<1mg/100g FW,
data not shown). Phenolic compounds such as the natural
antioxidants in plants may help to protect cells against the
oxidative damage caused by neutralized free radicals [39]
ThepresentstudyshowsthatRMDcontainingaconsiderable
amount of phenolic acid which may be useful in relation to
diabetes involving oxidative stress.
3.2. Eﬀect of Red Mold Dioscorea on Attenuating Symptoms of
Diabetes. Before streptozotocin injection, the average level
of blood glucose of experimental animals was 129.8 ±
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Figure 1: Chromatograms for phenolic acid. Phenolic acid stan-
dards (a). Phenolic acids composition of red mold dioscorea (b).
10.8mg/dL (data not show). After the experimental period,
there was a signiﬁcant increase in the levels of blood glucose,
glycosylated hemoglobin (HbA1c) and free fatty acid (FFA).
Concomitant decrease in the levels of insulin and total
protein in the diabetic control group was shown in Table 1.
As for the treatment groups (DM + 1X D, DM + 1X RMD,
and DM + 5X RMD), the blood glucose and FFA levels
were decreased, and the insulin level was increased. Levels of
HbA1candtotalproteinwerechanged onlyinthegroupwith
5X RMD. Rats in the diabetic control group had worse lipid
proﬁles than the normal control ones (Table 2). Signiﬁcant
(P<. 05) increases in total cholesterol (TC), triglyceride
(TG),and lowdensity lipoprotein (LDL)levelsand decreases
in high density lipoprotein (HDL) level were observed in
the diabetic control group. The degraded lipid proﬁles of
TC and LDL of the STZ-induced diabetic groups improved
with treatment (DM + 1X D, DM + 0.5X RMD, DM + 1X
RMD, and DM + 5X RMD). Groups DM + 1X RMD and
DM + 5X RMD had a signiﬁcant (P<. 05) decrease in
TG, TC, and LDL and an increase in HDL levels compared
to the diabetic control group. Greater hypoglycemic and4 Experimental Diabetes Research
Table 1: Eﬀect of red mold dioscorea on biochemistry parameters in STZ-induced diabetic rats.
Groups Glucose Insulin HbA1c FFA Total protein
mg/dL mmol/mL % mmol/L g/dL
Normal control (NC) 143.6 ± 8.5 153.7 ± 11.2 4.2 ± 0.2 0.9 ± 0.1 6.7 ± 0.2
Diabetic control (DC) 438.3 ± 25.5 48.2 ± 9.1 7.5 ± 0.2 1.3 ± 0.8 5.4 ± 0.4
DM + 1X D 383.8 ± 39.2∗ 80.5 ± 9.6∗ 7.0 ± 0.7 0.8 ± 0.2∗ 5.8 ± 0.6
DM + 0.5X RMD 392.9 ± 22.6 72.5 ± 9.5∗ 7.3 ± 0.4 0.9 ± 0.1 5.8 ± 0.4
DM + 1X RMD 380.6 ± 41.0∗ 83.9 ± 12.5∗ 7.2 ± 0.5 0.8 ± 0.4∗ 5.9 ± 0.5
DM + 5X RMD 370.2 ± 35.7∗ 93.3 ± 15.8∗ 6.1 ± 1.1∗ 0.7 ± 0.2∗ 6.5 ± 1.0∗
FFA: free fatty acid; HbA1c: glycosylated hemoglobin; DM: diabetes mellitus; D: dioscorea; RMD: red mold dioscorea. Values are expressed as mean ± SD
(n = 6). ∗P<. 05 versus the diabetic control.
Table 2: Eﬀect of red mold dioscorea on serum lipid proﬁle in STZ-induced diabetic rats.
Groups TG TC HDL-C LDL-C TC/HDL
mg/dL
Normal control (NC) 89.4 ± 13.3 74.8 ± 9.2 58.2 ± 5.8 10.5 ± 3.0 1.29 ± 0.02
Diabetic control (DC) 332.0 ± 49.0 127.7 ± 38.0 48.1 ± 8.1 18.2 ± 6.7 2.65 ± 0.04
DM + 1X D 268.6 ± 84.1 78.2 ± 20.1∗ 48.6 ± 8.6 9.2 ± 3.6∗ 1.61 ± 0.05∗
DM + 0.5X RMD 270.4 ± 58.6 89.7 ± 27.1∗ 49.3 ± 8.1 9.4 ± 3.7∗ 1.82 ± 0.09∗
DM + 1X RMD 217.8 ± 51.2∗ 83.3 ± 19.5∗ 52.2 ± 5.7∗ 10.1 ± 1.7∗ 1.59 ± 0.06∗
DM + 5X RMD 193.4 ± 37.5∗ 78.3 ± 17.4∗ 56.0 ± 5.2∗ 9.9 ± 3.4∗ 1.40 ± 0.04∗
TG: triglyceride; TC: total cholesterol; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; DM: diabetes mellitus; D:
dioscorea; RMD: red mold dioscorea. Values are expressed as mean ± SD (n = 6). ∗P<. 05 versus the diabetic control.
hypolipidemic eﬀects in the STZ-induced diabetic rats were
observed in the rats receiving 1X RMD and 5X RMD.
3.3. Eﬀect of Red Mold Dioscorea on Organ Weight Change.
The liver weight per body weight in all STZ-treated groups
was higher than in the normal control group (Table 3).
Similarly, the kidney weight per body weight in all STZ-
treated groups was higher than in the normal control group.
Treating the STZ-induced rats with dioscorea and diﬀerent
doses of RMD had reduced the degree of renal hypertrophy
at the termination of the eight-week treatment (Table 3).
3.4. Eﬀect of Red Mold Dioscorea on Antioxidant Enzymes in
Pancreas. An increase in the production of tissue-damaging
ROS by glucose autoxidation and nonenzymatic protein gly-
cosylation was observed in diabetes [40]. Using antioxidants
to protect the oxidative damage to the pancreatic cells has a
therapeutic eﬀect on diabetes. The ROS level of the pancreas
was generated in abundance by the STZ-induced diabetic
group compared to the normal group (Figure 2). Groups
with treatment (1X D, 1X RMD and 5X RMD) provided
as i g n i ﬁ c a n t( P<. 05) reduction of ROS in the pancreas
(data not show). The activities of enzymatic antioxidants
(GR, GPx, SOD, and CAT) were constantly and signiﬁcantly
(P<. 05) decreased in the STZ-induced diabetic group
compared to the normal control group. The GPx activities of
the pancreas were increased in all of the treatment groups.
The GR, CAT, and SOD activities of the pancreas were
increased in the groups of DM + 1X D, DM + 1X RMD, and
DM + 5X RMD. These results indicated an enhancement of
theenzymeactivitywhentreatingthe1XRMDand5XRMD.
3.5. Eﬀect of Red Mold Dioscorea on Splenocytes Proliferation.
Lymphocyte playsan important rolein theimmune function
and ensures a functional repertoire of mature B and T cells
[41, 42]. The mitogen (PHA and LPS) response of spleno-
cytes showed a signiﬁcant (P<. 05) decrease in the diabetic
control rats compared to normal control rats (Figure 3).
The groupsincreased the proliferationactivity ofsplenocytes
with treatment. The results suggest that dioscorea and RMD
have beneﬁcial eﬀects on improving the state of a decreased
cellular immune function in STZ-induced diabetic rats.
3.6. Eﬀect of Red Mold Dioscorea on Cytokines Production.
The fact that diabetes mellitus shares similarities with in-
ﬂammatory diseases is considered to play a role in diabetic
complications[43]. The cytokinelevelsofTNF-α,I L - 1 β,a n d
IL-6 were increased inthe patientswith diabetes and diabetic
rats [43, 44]. In our study, RMD treatments reduced the
TNF-αlevelinthepancreas andkidneys(Table 4).IFN-γ and
IL-6 levels in the kidneys were decreased in all of the treated
groups, and the level of IL-1β in the pancreas was decreased
only in DM + 1X RMD, and DM + 5X RMD treated rats.
SpleenexpressionofIFN-γ levelintheDM+ 5XRMDgroup
was signiﬁcantly (P<. 05) lower than in the diabetic control
group.SpleenexpressionofIL-1βlevelinthediabeticcontrol
group was signiﬁcantly (P<. 05) higher than the DM + 1X
D, DM + 1X RMD and DM + 5X RMD groups. The level of
IL-2 was increased in the pancreas, kidney and spleen.
3.7. Immunohistochemical Evaluation on Pancreas. An imm-
unohistochemical analysis of the pancreatic tissues is shown
in Figure 4. In the normal control group, the isletsExperimental Diabetes Research 5
Table 3: Eﬀect of red mold dioscorea on tissue weight of STZ-induced diabetic rats.
Groups Whole body weight % of body weight
g Heart Lung Liver Kidney
Normal control (NC) 404.8 ± 44.5 0.39 ± 0.03 0.57 ± 0.11 3.47 ± 0.18 0.94 ± 0.04
Diabetic control (DC) 294.6 ± 73.3 0.47 ± 0.18 0.62 ± 0.17 4.71 ± 1.44 1.43 ± 0.47
DM + 1X D 291.9 ± 27.7 0.47 ± 0.08 0.56 ± 0.07 4.50 ± 0.47∗ 1.21 ± 0.47∗
DM + 0.5X RMD 280.6 ± 38.8 0.43 ± 0.06 0.57 ± 0.07 4.18 ± 0.34∗ 1.16 ± 0.11∗
DM + 1X RMD 289.1 ± 58.2 0.41 ± 0.05 0.59 ± 0.03 4.20 ± 0.58∗ 1.14 ± 0.18∗
DM + 5X RMD 329.5 ± 73.2 0.39 ± 0.10 0.58 ± 0.17 4.06 ± 1.23∗ 1.02 ± 0.16∗
DM: diabetes mellitus;D: dioscorea; RMD: red mold dioscorea. Values are expressed as mean ± SD (n = 6). ∗P<. 05 versus the diabetic control.
0
1
2
3
4
5
6
∗
∗
∗
∗
∗
S
O
D
a
c
t
i
v
i
t
y
(
u
n
i
t
/
m
g
p
r
o
t
e
i
n
)
N
C
D
C
Groups
D
M
+
1
X
D
D
M
+
0
.
5
X
R
M
D
D
M
+
1
X
R
M
D
D
M
+
5
X
R
M
D
(a)
G
R
a
c
t
i
v
i
t
y
(
n
m
o
l
G
S
S
G
/
m
i
n
/
m
g
p
r
o
t
e
i
n
)
N
C
D
C
Groups
0
1
2
3
4
5
6
7
∗ ∗
∗
∗
D
M
+
1
X
D
D
M
+
0
.
5
X
R
M
D
D
M
+
1
X
R
M
D
D
M
+
5
X
R
M
D
(b)
G
P
x
a
c
t
i
v
i
t
y
(
n
m
o
l
G
S
S
G
/
m
i
n
/
m
g
p
r
o
t
e
i
n
)
0
5
10
15
20
25
30
35
N
C
D
C
Groups
∗
∗
∗ ∗
∗
D
M
+
1
X
D
D
M
+
0
.
5
X
R
M
D
D
M
+
1
X
R
M
D
D
M
+
5
X
R
M
D
(c)
∗
∗ ∗ ∗
C
A
T
a
c
t
i
v
i
t
y
(
n
m
o
l
H
2
O
2
/
m
i
n
/
m
g
p
r
o
t
e
i
n
)
0
10
20
30
40
50
60
N
C
D
C
Groups
D
M
+
1
X
D
D
M
+
0
.
5
X
R
M
D
D
M
+
1
X
R
M
D
D
M
+
5
X
R
M
D
(d)
Figure 2: Eﬀect of red mold dioscorea on antioxidant enzyme activity in the pancreas. Superoxide dismutase (SOD) (a). Glutathione
reductase (GR) (b). Glutathioneperoxidase (GPx)(c). Catalase(CAT) (d).NC: normalcontrol; DC: diabetic control; DM: diabetes mellitus;
D: dioscorea; RMD: red mold dioscorea. Data are presented as the means ± SD (n = 6). ∗P<. 05 versus the diabetic control.6 Experimental Diabetes Research
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Figure 3: Relative proliferation of splenocyte from rats with red mold dioscorea treatment. Splenocytes were stimulated with PHA (a) and
LPS (b). NC: normal control; DC: diabetic control; DM: diabetes mellitus; D: dioscorea; RMD: red mold dioscorea. ∗P<. 05 versus the
diabetic control.
Table 4: Eﬀect of red mold dioscorea on inﬂammatory cytokines in STZ-induced diabetic rats.
Pancreas
Cytokine type (pg/mL) NC DC DM + 1X D DM + 0.5X RMD DM + 1X RMD DM + 5X RMD
TNF-α 52.2 ± 8.4 158.2 ± 20.5 114.1 ± 14.4∗∗ 116.0 ± 17.1∗∗ 108.8 ± 19.1∗∗ 97.6 ± 23.2∗∗
IL-1β 19.5 ± 5.9 40.9 ± 9.8 33.3 ± 6.4 34.3 ± 5.6 31.5 ± 3.8∗ 29.8 ± 9.8∗∗
IL-2 119.5 ± 18.0 56.7 ± 13.8 136.7 ± 32.4∗ 129.4 ± 27.2∗ 148.0 ± 9.7∗ 140.5 ± 12.7∗
IL-6 38.4 ± 7.9 95.5 ± 16.0 83.3 ± 11.3 84.9 ± 10.7 80.4 ± 10.3 77.2 ± 10.3
Kidney
IFN-γ 10.6 ± 2.0 30.4 ± 3.9 23.2 ± 3.5∗ 23.2 ± 3.9∗ 21.6 ± 2.6∗ 21.1 ± 5.3∗
TNF-α 28.8 ± 6.4 147.7 ± 13.5 119.0 ± 10.6∗∗ 122.6 ± 9.3∗∗ 119.4 ± 22.8∗∗ 115.6 ± 9.2∗∗
IL-6 53.2 ± 8.5 186.6 ± 18.9 152.7 ± 13.2∗∗ 156.3 ± 28.0∗∗ 147.0 ± 20.5∗∗ 140.6 ± 10.8∗∗
IL-1β 9.7 ± 1.6 16.2 ± 2.9 15.7 ± 2.2 15.7 ± 2.2 15.6 ± 1.3 15.1 ± 1.5
IL-2 55.8 ± 9.0 44.9 ± 8.8 75.0 ± 19.0∗ 69.1 ± 15.7∗ 80.4 ± 23.3∗ 82.9 ± 18.3∗∗
Spleen
TNF-α 65.3 ± 16.1 131.6 ± 24.6 124.3 ± 56.9 123.0 ± 8.7 123.2 ± 25.1 122.4 ± 27.2
IFN-γ 14.0 ± 2.1 42.7 ± 7.0 36.6 ± 5.6 39.4 ± 7.8 36.2 ± 9.4 32.8 ± 5.2∗
IL-1β 25.4 ± 5.1 36.9 ± 5.1 32.0 ± 2.9∗ 32.9 ± 5.5 30.7 ± 3.6∗ 30.1 ± 2.0∗
IL-2 33.8 ± 9.5 13.8 ± 2.5 23.0 ± 5.4∗ 22.9 ± 6.1∗ 25.3 ± 2.7∗ 27.6 ± 4.6∗
NC: normal control; DC: diabetic control; DM: diabetes mellitus; D: dioscorea; RMD: red mold dioscorea. Values are expressed as mean ± SD (n = 6). ∗P<
.05; ∗∗P <. 01 versus the diabetic control.
showed the normal structure by insulin-secreting β-cells
(Figure 4(a)). The islets of the pancreatic of the diabetic
control group, theinsulin immunoreactivity and the number
of immunoreactivity of β-cells were decreased (Figure 4(b)).
The diabetic rats given 0.5X RMD showed no diﬀerence
from the diabetic control rats (Figure 4(d)). In contrast,
the diabetic rats given 1X D, 1X RMD, and 5X RMD
resulted in a signiﬁcant (P<. 05) increase in the insulin
immunoreactivity, and a number of β-cells were observed
in the pancreatic islets compared with diabetic control rats
(Figures 4(c), 4(e),a n d4(f)). The result of the image
analysis of the insulin immunoreactivity of β-cells is shown
in Figure 5. After being treated with 1X D, 1X RMD, and
5X RMD, the insulin immunoreactivity was relatively more
frequent than the diabetic control group, especially when
t r e a t e dw i t h1 XR M Da n d5 XR M D( Figure 5). The results
indicate that RMD have a cytoprotective eﬀect in pancreatic
tissues.Experimental Diabetes Research 7
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Figure 4: Immunohistochemicalevaluation on pancreas (400x). Normal control (a). Diabetic control (b). Diabetic + 1X D (dioscorea) (c).
Diabetic + 0.5X RMD (red mold dioscorea) (d). Diabetic + 1X RMD (red mold dioscorea) (e). Diabetic + 5X RMD (red mold dioscorea)
(f).
4.Discussion
Hyperglycemia, an indicator for abnormal glucose home-
ostasis, is related to diabetes, incidences of obesity, and car-
diovascular risk, inducing peripheral insulin resistance [45].
Recent studies indicate that hyperglycemia-induced diabetic
complications are likely from oxidative dysfunction and
inﬂammatory eﬀect [5, 6]. The Monascus species can pro-
duce multifunctional compounds; the composition of incu-
bation substrates is an important factor for the production
of secondary metabolites [46]a n dt h eg r o w t ho fMonascus
spp. In our previous study, RMD had greater hypolipidemic,
antiatherosclerotic, and antihypertension eﬀects than red
mold rice (RMR) and unfermented dioscorea [20, 47]. RMR
contains various antioxidants, including dimerumic acid,
organic acid, tannin, and phenolic content [20]. Our present
study provides in vivo data to elucidate the antioxidative and
anti-inﬂammatory eﬀects of RMD in diabetic rats. In the
HPLC assay, we found that RMD has diﬀerent phenolic acid
compounds, such as gallic acid, vanillic acid, caﬀeic acid,
coumaric acid, and epicatechin (Figure 1(b)). Those pheno-
lic acids, as antioxidants, have several biological activities to
reduce lipid peroxyl radicals, inhibit lipid peroxidation, and
protect our cells against oxidative damage [48, 49].
Elevated levels of free fatty acid have been inhibiting
insulinsecretion bymitochondrial oxidationintheestablish-
ment of insulin resistance in diabetes mellitus [50]. Plasma
FFA levels are commonly associated with impaired insulin-
mediated glucose uptake in related tissues, and coexist with
type 2 diabetes and obesity [51]. Plasma total protein can be8 Experimental Diabetes Research
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Figure 5: Comparative evaluation of the expression of insulin
immunoreactivity in pancreas. NC: normal control; DC: diabetic
control; DM: diabetes mellitus; D: dioscorea; RMD: red mold
dioscorea. Data are presented as the means ± SD (n = 6). ∗P<. 05
versus the diabetic control.
used to test the eﬀectsof treatment in diabetes and nephrotic
syndrome [52]. The current study shows a signiﬁcant (P<
.05) decrease in blood glucose and the FFA levels of STZ-
induced diabetic rats with RMD treatment (Table 1). The
insulin level was increased in all groups with treatment. Low
total protein can result from protein loss such as nephrosis,
glomerulonephritis, chronic liver disease, and hemorrhage.
Levels of HbA1c and total protein were decreased and
increased, respectively, only in DM + 5X RMD rats. This
result provides direct proof of the antihyperglycemic and
anti-inﬂammatory-like functions of RMD.
Manystudieshaveattemptedtodetermineifantioxidants
can actually prevent the oxidation of LDL and slow the
progression of atherosclerosis [53]. Other studies suggest
that diabetic individualsmay havean increased susceptibility
to LDL oxidation [53]. High triglyceride levels in the blood
tend to coexist with low levels of high-density lipoprotein
(HDL), contributing to a condition called diabetic dyslipi-
demia or hypertriglyceridemia [54]. The cholesterol and
triglycerides cause a risk of heart disease, which should be
as tightly controlled as possible in diabetes mellitus [55].
The present study demonstrates that dioscorea and RMD
can signiﬁcantly lower serum TC and LDL levels (P<
.05) (Table 2). Levels of TG and HDL were decreased and
increased respectively only in DM + 1X RMD and DM + 5X
RMD rats.
Renal hypertrophy is an important early manifestation
of both experimental and human diabetes, although the
metabolic events responsible for its development are not
yet completely understood. The kidneys are enlarged in
diabetes mellitus when they have microalbuminuria or overt
levels of albumin excretion [56]. A raised level of albumin
in the urine is a typical indicator that the kidneys have
been injured by diabetes [57]. Excess body weight has an
adverse eﬀect on the liver, and can increase the risk of the
development of metabolic symptoms [58]. The indices of
kidney weight/body weight and liver weight/body weight
ratio are shown in Table 3. The liver weight was increased in
all of the STZ-induced diabetic rats, although the increases
tended to be less in the rats treated with dioscorea and RMD.
The kidney weight in diabetic control rats was signiﬁcantly
(P<. 001) greater than it was in normal control rats. The
kidneys of diabetic rats with treatment were signiﬁcantly
(P<. 05) lower than they were in diabetic control rats,
especially those treated with 5X RMD. Although STZ-
induced diabetic rats showed liver and kidney hypertrophy,
the measurement of other indicators such as histopathology
is needed to be further investigated.
Ad i a b e t o g e n i ce ﬀect of STZ was observed due to the
excess production of ROS, which led to cytotoxicity in pan-
creatic β-cells [59]. Oxidative stress may be an important
factor in the pathogenesis of diﬀerent diabetic complications
[60]. Reduced activities of GR, GPx, CAT, and SOD in
pancreas of diabetic control rats were observed in our study
(Figure 2). Treatment with dioscorea and RMD reversed this
change. Thus, it is possible that dioscorea and RMD pre-
vented ROS-induced damage to the elevation of antioxidant
enzymes activities. According to the results, RMD may have
an antioxidative eﬀect against the pathological alterations
caused by ROS.
In diabetes, the suppressed proliferation potential of dia-
betic T lymphocytes with mitogen stimulated was achieved
by a decreased expression of adenosine kinase [60], and
decreased IL-2 production by mitogen-stimulated diabetic
T cells has been reported [61]. These mechanisms are still
unclear as to why these cells display an impaired prolifer-
ative response to primary antigens. In our study, similar
results have been observed, in that the mitogen response
of splenocytes showed a signiﬁcant (P<. 05) decrease in
the diabetic control rats, and rats with treatment had an
increased proliferationactivityofsplenocytes(Figure 3).The
dioscorea and RMD have beneﬁcial eﬀects on enhancing
spleen cells viability and improving the state of decreased
cellular immune function in diabetic rats. Our present study
found that RMD treatments reduced IFN-γ,I L - 1 β,I L - 6 ,a n d
TNF-α levels in the pancreas, the kidney, and the spleen
(Table 4). The level of IL-2 was increased in the pancreas,
kidney and spleen. The level of TNF-α was no diﬀerent in
the spleen. The levels of IL-6 and IL-1β were no diﬀerent
in the pancreas and the kidney, respectively. The ﬁrst factor
at the crossroads of inﬂammation and metabolic disease was
TNF-α. The production of excess TNF-α in tissue was due to
insulin resistance [12]. The islet inﬂammatory process in the
diabetic rats showed an increased islet expression of IL-1β,
IL-6, and TNF-α [62]. The increased production of IL-6 and
IFN-γ bySTZ-induceddiabeticratswasidentiﬁedasautoim-
mune diabetes [63]. The kidney macrophages can produce a
variety of substances which can promote renal injury, such
as nitric oxide, ROS, IFN-γ,a n dI L - 1 ,a n dT N F - α resulted
in renal injury in diabetic nephropathy [64]. IL-2 has a well-
established function to promote T-cell proliferation and low
production in STZ-induced diabetic rats [65]. These resultsExperimental Diabetes Research 9
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Figure 6:Thehypothetical diagramofpreventionapproach ofred molddioscoreawithdiabetic oxidative stress andinﬂammatoryresponse.
support the fact that RMD is a potent agent against diabetes-
associated inﬂammatory injury via inhibiting inﬂammatory
cytokines production and enhancing IL-2 expression.
The beneﬁcial eﬀects of RMD observed in the present
study were the maintenance of glucose homeostasis, the pre-
vention of oxidative stress and inﬂammatory activities, and
the protection of pancreatic β-cells. A hypothetical diagram
ofthepreventativeapproach ofredmoldfermentedproducts
was presented (Figure 6). The role of RMD in controlling
diabetic-reactive inﬂammation is unclear, and further study
is necessary on RMD to determine the interaction between it
and diabetes-associated symptoms.
5.Conclusion
T h ep a t h o g e n e s i so fd i a b e t e sa n dd i a b e t e sc o m p l i c a t i o n s
is complex. RMD, a novel red mold fermented product,
has a beneﬁcial eﬀect in the STZ-induced diabetic animal
model. The present investigation shows that RMD possesses
several treatment-oriented properties, including the control
of hyperglycemia, antioxidant eﬀects, pancreatic β-cell pro-
tection, and anti-inﬂammatory eﬀects. Considering these
observations, it appears that RMD may be a useful adjunct
supplement to delay the development of diabetes and dia-
betes complications. However, more work is necessary to
further elucidate the role of RMD, particularly looking at the
underlying mechanism of treatment.
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